Zimmer Biomet Holdings, Inc. (ZBH) Enterprise Value (EV): $23.95B
The enterprise value (EV) for Zimmer Biomet Holdings, Inc. (ZBH) is $23.95B as of Saturday, June 20, 2026.
ZBH Enterprise Value (EV) Metrics
ENTERPRISE VALUE (EV)
$23.95B
ZBH Competitors' Enterprise Value (EV)
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Zimmer Biomet Holdings, Inc. (ZBH) | $17.02B | $23.95B |
| Hologic, Inc. (HOLX)vs › | $16.97B | $15.94B |
| DaVita Inc. (DVA)vs › | $13.34B | $24.07B |
| Medpace Holdings, Inc. (MEDP)vs › | $13.14B | $15.95B |
| Solventum Corporation (SOLV)vs › | $13.06B | $17.95B |
| Labcorp Holdings Inc. (LH)vs › | $20.98B | $27.54B |
| Align Technology, Inc. (ALGN)vs › | $13.04B | $10.36B |
| The Cooper Companies, Inc. (COO)vs › | $12.85B | $16.66B |
| United Therapeutics Corporation (UTHR)vs › | $22.78B | $20.03B |
| Revvity, Inc. (RVTY)vs › | $11.16B | $13.59B |
Enterprise Value Calculation
Market Cap
$17.02B
Total Debt
$7.52B
Cash
$591.90M
Enterprise Value
$23.95B
EV-Based Valuation Multiples
Why use EV instead of Market Cap?
- EV accounts for debt - an acquirer must pay or assume it
- EV deducts cash - the acquirer effectively receives it
- EV enables fair comparison of companies with different capital structures
- EV-based ratios (EV/EBITDA, EV/Sales) are capital structure neutral
Zimmer Biomet Holdings, Inc. Enterprise Value (EV) Formula & Definition
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Zimmer Biomet Holdings, Inc. Enterprise Value (EV) FAQ
- What is the enterprise value (EV) for Zimmer Biomet Holdings, Inc. (ZBH)?
- The enterprise value (EV) for ZBH stock is $23.95B.
Related Metrics
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ivan Tornos